Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed in the study history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check68 days agoChange DetectedThe revision history shows a new revision label (v3.4.2) replacing the previous v3.4.1; this is a cosmetic update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedUI updates on the record history page add a glossary toggle, emphasize changes with green/red highlights, and show revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.